Learn about the approach of genes to drugs using NGS data analysis, modelling, simulation, and other machine learning methods.
Dassault Systèmes, with its diverse scientific portfolio, offers state-of-the-art approaches to biomarker identification (including genes, SNPs, proteomic biomarkers, and indels) to target protein and antibody identification, alongside lead identification and optimization.
In collaboration with our valued partner Sigma Solutions, our expert will walk you through the approach of genes to drugs using NGS data analysis, modeling, simulation, and other machine learning methods.
(While the webinar will be presented in English, please note that it will be moderated in Thai.)
